Treatment for psoriasis with modified Goeckerman regimen - One year experience in southern Taiwan

Dermatologica Sinica

Volumn 23, Issue 3, 2005, Pages 113-120

  Lai, Chih Sheng ^a   Huang, Po Han ^a   Ho, Ji Chen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Goeckerman regimen; Phototherapy; Psoriasis; Tar; Ultraviolet

Indexed keywords

CALCIPOTRIOL; TAR;

ADOLESCENT; ADULT; AGED; ARTICLE; BURN; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LENTIGO; LICHENOID ERUPTION; MALE; MEDICAL LITERATURE; PRURITUS; PSORIASIS; REMISSION; SCORING SYSTEM; TAIWAN; ULTRAVIOLET B RADIATION;

EID: 24644486579     PISSN: 10278117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Farber EM, Nail L: Epidemiology: Natural History and Genetics. In: Roegnigk HH, Maibach HI, eds. Psoriasis. 3rd ed. New York:Marcel Dekker, 107-157, 1998.
2. Christophers E, Mrowietz U: Psoriasis. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York:McGraw-Hill, 407-427, 2003.
3. Yip SY: The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol. 10: 965-968, 1984.
4. Muller SA, Perry HO: The Goeckerman treatment in psoriasis: six decades of experience at the Mayo Clinic. Cutis 34: 265-269, 1984.
5. Krueger GG, Feldman SR, Camisa C, et al.: Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 43: 281-285, 2000.
6. Lebwohl MG, Feldman SR, Koo JYM, et al.: Psoriasis: Treatment options and patient management. National Psoriasis Foundation, 1-5, 2002.
7. Spuls PI, Witkamp L, Bossuyt PMM, et al.: A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol 137: 943-949, 1997.
8. Heydendael VMR, Spuls PI, Opmeer BC, et al.: Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 349: 658-665, 2003.
9. Menter A, Cram DL: The Goeckerman regimen in two psoriasis day care centers. J Am Acad Dermatol 9: 59-65, 1983.
10. Camisa C: Handbook of psoriasis. 1st ed. Blackwell Science, 144-165, 1998.
11. Cort DH, Schleider NR, Moskowitz RS, et al.: Retrospective analysis of a modified Goeckerman regimen for the treatment of psoriasis. Cutis 25: 201-209, 1980.
12. DesGroseilliers JP, Cullen AE, Rouleau GA: Ambulatory Goeckerman treatment of psoriasis: experience with 200 patients. CMAJ 124: 1018-1020, 1981.
13. Koo J, Lebwohl M: Duration of remission of psoriasis therapies. J Am Acad Dermatol 41: 51-59, 1999.
14. Krueger GG, Callis KP: Development and use of alefacept to treat psoriasis. J Am Acad Dermatol 49: S87-S97, 2003.
15. Leonardi CL: Efalizumab: an overview. J Am Acad Dermatol 49: S98-S104, 2003.
16. Goffe B, Cather JC: Etanercept: an overview. J Am Acad Dermatol 49: S105-S111, 2003.
17. Gottlieb AB: Infliximab for psoriasis. J Am Acad Dermatol 49: 8112-8117, 2003.
18. Yamauchi PS, Rizk D, Kormeili T, et al.: Current systemic therapies for psoriasis: Where are we now? J Am Acad Dermatol 49: S66-S77, 2003.
19. Perry HO, Soderstrom CW, Schulze RW, et al.: The Goeckerman treatment of psoriasis. Arch Dermatol 98: 178-182, 1968.
20. LeVine MJ: Does tar belong in the Goeckerman regimen? Int J Dermatol 21: 331-332, 1982.